Division of Genetics and Cell Biology, San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.
Division of Genetics and Cell Biology, San Raffaele Scientific Institute, Milan, Italy.
Trends Cell Biol. 2021 Jul;31(7):529-541. doi: 10.1016/j.tcb.2021.02.004. Epub 2021 Mar 5.
The biosynthesis of about one third of the human proteome, including membrane receptors and secreted proteins, occurs in the endoplasmic reticulum (ER). Conditions that perturb ER homeostasis activate the unfolded protein response (UPR). An 'optimistic' UPR output aims at restoring homeostasis by reinforcement of machineries that guarantee efficiency and fidelity of protein biogenesis in the ER. Yet, once the UPR 'deems' that ER homeostatic readjustment fails, it transitions to a 'pessimistic' output, which, depending on the cell type, will result in apoptosis. In this article, we discuss emerging concepts on how the UPR 'evaluates' ER stress, how the UPR is repurposed, in particular in B cells, and how UPR-driven counter-selection of cells undergoing homeostatic failure serves organismal homeostasis and humoral immunity.
人类蛋白质组约三分之一的生物合成,包括膜受体和分泌蛋白,发生在内质网(ER)中。扰乱 ER 稳态的条件会激活未折叠蛋白反应(UPR)。UPR 的“乐观”输出旨在通过加强保证 ER 中蛋白质生物发生效率和保真度的机制来恢复稳态。然而,一旦 UPR“认为”ER 稳态调整失败,它就会过渡到“悲观”输出,根据细胞类型的不同,这将导致细胞凋亡。在本文中,我们讨论了 UPR 如何“评估”ER 应激、UPR 如何被重新利用,特别是在 B 细胞中,以及 UPR 驱动的对经历稳态失效的细胞进行的反向选择如何服务于机体稳态和体液免疫的新兴概念。